| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b58f981963f6d55d627139e778c4ef7b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 |
| filingDate |
2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4497b434aa7d221c4c7ef5b126d1c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f3095eceb25f98cee2717d94fea9279
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d97c151e04e4008372c59cb663b3dd9d |
| publicationDate |
2016-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016066789-A1 |
| titleOfInvention |
Use of par-1 antagonists for the prevention and/or treatment of pelvic-perineal functional disorders |
| abstract |
The present invention relates to the use of PAR-1 antagonists, in particular vorapaxar and atopaxar, with the exception of 3-(2-chloro-phenyl)-1-[4-(4-fluoro-benzyl)-piperazin-1-yl]-propenone, or any of the pharmaceutically acceptable salts thereof for the prevention and/or treatment of pelvic-perineal functional disorders, and specifically of cystic pain syndrome. |
| priorityDate |
2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |